Marianne K Melnik

Summary

Publications

  1. doi request reprint Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer
    Marianne K Melnik
    Grand Rapids Clinical Oncology Program, Michigan State University, East Lansing, Michigan, USA
    Mol Cancer Ther 9:2423-9. 2010

Detail Information

Publications1

  1. doi request reprint Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer
    Marianne K Melnik
    Grand Rapids Clinical Oncology Program, Michigan State University, East Lansing, Michigan, USA
    Mol Cancer Ther 9:2423-9. 2010
    ..The primary dose-limiting toxicities were hematologic toxicity and fatigue. These results show that the gemcitabine and etoposide combination is generally well-tolerated and exhibits a response rate similar to other published studies...